These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29067486)

  • 1. Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Petrie JR; Peters AL; Bergenstal RM; Holl RW; Fleming GA; Heinemann L
    Diabetologia; 2017 Dec; 60(12):2319-2328. PubMed ID: 29067486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Petrie JR; Peters AL; Bergenstal RM; Holl RW; Fleming GA; Heinemann L
    Diabetes Care; 2017 Dec; 40(12):1614-1621. PubMed ID: 29070577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
    Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D
    J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Personalized Week-to-Week Updating Algorithm to Improve Continuous Glucose Monitoring Performance.
    Zavitsanou S; Lee JB; Pinsker JE; Church MM; Doyle FJ; Dassau E
    J Diabetes Sci Technol; 2017 Nov; 11(6):1070-1079. PubMed ID: 29032732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation.
    Aleppo G; Webb K
    J Diabetes Sci Technol; 2019 Jul; 13(4):664-673. PubMed ID: 30453772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursement for Continuous Glucose Monitoring.
    Heinemann L; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S248-52. PubMed ID: 26784130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
    Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
    Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
    Moser O; Riddell MC; Eckstein ML; Adolfsson P; Rabasa-Lhoret R; van den Boom L; Gillard P; Nørgaard K; Oliver NS; Zaharieva DP; Battelino T; de Beaufort C; Bergenstal RM; Buckingham B; Cengiz E; Deeb A; Heise T; Heller S; Kowalski AJ; Leelarathna L; Mathieu C; Stettler C; Tauschmann M; Thabit H; Wilmot EG; Sourij H; Smart CE; Jacobs PG; Bracken RM; Mader JK
    Diabetologia; 2020 Dec; 63(12):2501-2520. PubMed ID: 33047169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study.
    Yu F; Lv L; Liang Z; Wang Y; Wen J; Lin X; Zhou Y; Mai C; Niu J
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4674-82. PubMed ID: 25057872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges.
    Wood A; O'Neal D; Furler J; Ekinci EI
    Intern Med J; 2018 May; 48(5):499-508. PubMed ID: 29464891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
    Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M
    Diabetologia; 2023 Jan; 66(1):3-22. PubMed ID: 36198829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.
    Jendle J; Testa MA; Martin S; Jiang H; Milicevic Z
    Diabetes Obes Metab; 2016 Oct; 18(10):999-1005. PubMed ID: 27279266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):250-260. PubMed ID: 31806649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CGM-Continuous Glucose Monitoring-Statement of the Austrian Diabetes Association (Update 2019)].
    Schütz-Fuhrmann I; Rami-Merhar B; Hofer SE; Fröhlich-Reiterer E; Mader J; Stadler M; Bischof M; Zlamal-Fortunat S; Laimer M; Weitgasser R
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):119-123. PubMed ID: 30980171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.
    Kovatchev BP; Patek SD; Ortiz EA; Breton MD
    Diabetes Technol Ther; 2015 Mar; 17(3):177-86. PubMed ID: 25436913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study.
    Basu A; Veettil S; Dyer R; Peyser T; Basu R
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S243-7. PubMed ID: 26784129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial Aspects of Continuous Glucose Monitoring: Connecting to the Patients' Experience.
    Kubiak T; Mann CG; Barnard KC; Heinemann L
    J Diabetes Sci Technol; 2016 Jul; 10(4):859-63. PubMed ID: 27234808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.